PLUVICTO

Google image searchProduct monograph

Active ingredient

lutetium (177lu) vipivotide tetraxetan, 1000 MBq/ML

DIN: 02530198

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-DOSE VIAL

Schedule: Schedule C

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 02-SEP-2024

ATC:

• V10 — THERAPEUTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
• V10X — OTHER THERAPEUTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD)
• V10XX — Various therapeutic radiopharmaceuticals (ATC, ATC/DDD)
• V10XX05 — LUTETIUM (177Lu) VIPIVOTIDE TETRAXETAN (ATC/DDD)

External Links for Pluvicto

Search on Google

• Pluvicto side effects
• Pluvicto dosage
• lutetium side effects
• lutetium dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find pluvicto photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.